Back to Menu
1. Clinical presentation assessment
A detailed history is obtained, including HPV infection and prior gynecologic disease. Comprehensive pelvic examination assesses tumor size, location, and extent of invasion.
2. Colposcopy
Colposcopic magnification of the vaginal wall identifies suspicious areas and guides biopsy, improving detection of early lesions.
3. Imaging examinations
Pelvic MRI delineates tumor extent and depth of invasion. CT and PET-CT evaluate lymph node involvement and distant metastasis.
4. Pathological biopsy
Biopsy of the lesion is the gold standard for confirmation, defining tumor type, grade, and depth of invasion to guide treatment.
5. Endoscopic evaluation
Cystoscopy and proctoscopy assess involvement of adjacent organs and provide critical information for accurate staging.
6. Tumor marker testing
HPV testing and related biomarkers may support diagnosis, assess response, and monitor recurrence.
7. Laparoscopy
Laparoscopic exploration of the pelvis and abdomen with removal of suspicious lymph nodes may be useful, particularly when ovarian preservation is considered in younger patients.
8. Comprehensive preoperative assessment
Includes complete blood count, liver and renal function tests, and cardiopulmonary evaluation to assess overall condition and ensure surgical safety.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that although vaginal cancer is uncommon, it poses a major threat to women’s health. Early symptoms are nonspecific and often overlooked, and many patients present at an advanced stage. Vigilance for abnormal bleeding is essential. High-risk individuals should undergo regular screening and seek timely medical evaluation. Early standardized treatment can improve prognosis, and MDT-based collaboration enhances diagnostic and therapeutic effectiveness.
1. Clinical presentation assessment
A detailed history is obtained, including HPV infection and prior gynecologic disease. Comprehensive pelvic examination assesses tumor size, location, and extent of invasion.
2. Colposcopy
Colposcopic magnification of the vaginal wall identifies suspicious areas and guides biopsy, improving detection of early lesions.
3. Imaging examinations
Pelvic MRI delineates tumor extent and depth of invasion. CT and PET-CT evaluate lymph node involvement and distant metastasis.
4. Pathological biopsy
Biopsy of the lesion is the gold standard for confirmation, defining tumor type, grade, and depth of invasion to guide treatment.
5. Endoscopic evaluation
Cystoscopy and proctoscopy assess involvement of adjacent organs and provide critical information for accurate staging.
6. Tumor marker testing
HPV testing and related biomarkers may support diagnosis, assess response, and monitor recurrence.
7. Laparoscopy
Laparoscopic exploration of the pelvis and abdomen with removal of suspicious lymph nodes may be useful, particularly when ovarian preservation is considered in younger patients.
8. Comprehensive preoperative assessment
Includes complete blood count, liver and renal function tests, and cardiopulmonary evaluation to assess overall condition and ensure surgical safety.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that although vaginal cancer is uncommon, it poses a major threat to women’s health. Early symptoms are nonspecific and often overlooked, and many patients present at an advanced stage. Vigilance for abnormal bleeding is essential. High-risk individuals should undergo regular screening and seek timely medical evaluation. Early standardized treatment can improve prognosis, and MDT-based collaboration enhances diagnostic and therapeutic effectiveness.